These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22844010)

  • 1. Cushing's syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection.
    Yoganathan K; David L; Williams C; Jones K
    Int J STD AIDS; 2012 Jul; 23(7):520-1. PubMed ID: 22844010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.
    Valin N; De Castro N; Garrait V; Bergeron A; Bouche C; Molina JM
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):113-21. PubMed ID: 19270151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature.
    Foisy MM; Yakiwchuk EM; Chiu I; Singh AE
    HIV Med; 2008 Jul; 9(6):389-96. PubMed ID: 18459946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen.
    Clevenbergh P; Corcostegui M; Gérard D; Hieronimus S; Mondain V; Chichmanian RM; Sadoul JL; Dellamonica P
    J Infect; 2002 Apr; 44(3):194-5. PubMed ID: 12099750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient.
    Kedem E; Shahar E; Hassoun G; Pollack S
    J Asthma; 2010 Sep; 47(7):830-1. PubMed ID: 20653496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
    Mahlab-Guri K; Asher I; Gradstein S; Zung A; Radian-Sade S; Elbirt D; Sthoeger Z
    J Asthma; 2011 Oct; 48(8):860-3. PubMed ID: 21854345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iatrogenic Cushing Syndrome in a 47-Year-Old HIV-Positive Woman on Ritonavir and Inhaled Budesonide.
    Colpitts L; Murray TB; Tahhan SG; Boggs JP
    J Int Assoc Provid AIDS Care; 2017; 16(6):531-534. PubMed ID: 29108449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases.
    Samaras K; Pett S; Gowers A; McMurchie M; Cooper DA
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4394-8. PubMed ID: 15755851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exogenous Cushing's syndrome as a serious side-effect of therapy with ritonavir an inhaled fluticasone].
    Machala L; Kréze A; Jilich D; Rozsypal H
    Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):103-5. PubMed ID: 21780031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone.
    Chen F; Kearney T; Robinson S; Daley-Yates PT; Waldron S; Churchill DR
    Sex Transm Infect; 1999 Aug; 75(4):274. PubMed ID: 10615321
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of fluconazole in a case of rapid onset ritonavir and inhaled fluticasone-associated secondary adrenal insufficiency.
    St Clair K; Maguire JD
    Int J STD AIDS; 2012 May; 23(5):371-2. PubMed ID: 22648897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iatrogenic Cushing syndrome in patients receiving inhaled budesonide and itraconazole or ritonavir: two cases and literature review.
    Blondin MC; Beauregard H; Serri O
    Endocr Pract; 2013; 19(6):e138-41. PubMed ID: 23807527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal insufficiency and exogenous Cushing's syndrome in a patient receiving inhaled fluticasone and ritonavir.
    Zubillaga I; Francés C; Nicolau J; Homar F; Masmiquel L
    Endocrinol Diabetes Nutr; 2017; 64(6):338-339. PubMed ID: 29056281
    [No Abstract]   [Full Text] [Related]  

  • 14. Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent.
    St Germain RM; Yigit S; Wells L; Girotto JE; Salazar JC
    AIDS Patient Care STDS; 2007 Jun; 21(6):373-7. PubMed ID: 17594245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal suppression and Cushing's syndrome secondary to ritonavir and budesonide.
    Gray D; Roux P; Carrihill M; Klein M
    S Afr Med J; 2010 May; 100(5):296-7. PubMed ID: 20460021
    [No Abstract]   [Full Text] [Related]  

  • 16. Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir.
    Hall JJ; Hughes CA; Foisy MM; Houston S; Shafran S
    Int J STD AIDS; 2013 Sep; 24(9):748-52. PubMed ID: 23970582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iatrogenic Cushing's syndrome after triamcinolone plus ritonavir-boosted atazanavir.
    Jakeman B; Conklin J; Bouchonville M; Thornton K
    J Am Pharm Assoc (2003); 2015; 55(2):193-7. PubMed ID: 25658506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole.
    Bolland MJ; Bagg W; Thomas MG; Lucas JA; Ticehurst R; Black PN
    Ann Pharmacother; 2004 Jan; 38(1):46-9. PubMed ID: 14742792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluticasone-ritonavir: a drug-drug interaction causing iatrogenic Cushing's syndrome and adrenal insufficiency].
    Rousseau C; Dolz M
    Med Mal Infect; 2014 Oct; 44(10):483-4. PubMed ID: 25282607
    [No Abstract]   [Full Text] [Related]  

  • 20. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone.
    Johnson SR; Marion AA; Vrchoticky T; Emmanuel PJ; Lujan-Zilbermann J
    J Pediatr; 2006 Mar; 148(3):386-8. PubMed ID: 16615973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.